Credelio Quattro Chewable Tablets for Dogs: 12.1-25 lbs. (Orange), 225 mg, 1 Count, Image 0

Credelio Quattro for Dogs

Prescription Required
We’ll contact your vet right after you purchase this item to make sure your pet needs it.
$33.48USD
$31.80USD
Saving 5%
Credelio Quattro for Dogs
$31.80 with autoship
Why Autoship?
Get up to 5% off
Refills arrive before you run out
Cancel any time
Product Description

Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is a broad parasite protection of its kind covering 6 types of parasites in one chewable tablet. It protects against ticks, fleas, heartworm disease and the three intestinal worms that can be passed to humans — tapeworms, roundworms and hookworms.

Credelio Quattro is effective and works fast where it counts. It kills >99% of fleas within 8 hours of administration and remains effective for an entire month.

This FDA-approved medication delivers all the protection your dog needs in a convenient monthly chewable. It uses four powerful ingredients to provide broad protection that lasts all month long by covering 6 types of parasites. Credelio Quattro comes in a tasty, easy-to-give chewable that's also meat allergy friendly.

Key Features
  • Credelio Quattro: broad parasite protection covering 6 types of parasites in one chewable tablet
  • Easy-to-Give Chewable: This FDA-approved parasite protection comes in a flavored chewable tablet that is given once a month with food
  • Prescription Only: Credelio Quattro is a prescription medication for puppies and dogs at least 8 weeks old and weighing at least 3.3 lbs.
  • IMPORTANT SAFETY INFORMATION

    Lotilaner, an ingredient in Credelio Quattro, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders.

    Dogs should be tested for existing heartworm infections before Credelio Quattro administration as it is not effective against adult D. immitis.

    The safe use in breeding, pregnant, or lactating dogs has not been evaluated.

    The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.